v3.26.1
SCHEDULE OF FAIR VALUE OF THE LEVELS 3 ASSETS AND LIABILITIES (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
Impairment Effects on Earnings Per Share [Line Items]  
Outstanding at December 31, 2024 $ 1,392
Additions during the period 1,889
Purchase of MitoCareX (1,106)
Transfers into Level 3 (see Note 10) 782
Changes in fair value 183
Outstanding at December 31, 2025 3,140
Outstanding at December 31, 2024 312
Additions during the period 6,117
Settlements of liabilities (3,934)
Changes in fair value 74
Outstanding at December 31, 2025 2,569
Solar Photovoltaic Joint Venture Project [Member]  
Impairment Effects on Earnings Per Share [Line Items]  
Outstanding at December 31, 2024 808
Additions during the period 1,017
Purchase of MitoCareX
Transfers into Level 3 (see Note 10)
Changes in fair value 919
Outstanding at December 31, 2025 2,744
Loan Granted to MitoCareX [Member]  
Impairment Effects on Earnings Per Share [Line Items]  
Outstanding at December 31, 2024 234
Additions during the period 872
Purchase of MitoCareX (1,106)
Transfers into Level 3 (see Note 10)
Changes in fair value
Outstanding at December 31, 2025
Convertible Loan to Solterra [Member]  
Impairment Effects on Earnings Per Share [Line Items]  
Outstanding at December 31, 2024 350
Additions during the period
Purchase of MitoCareX
Transfers into Level 3 (see Note 10)
Changes in fair value 46
Outstanding at December 31, 2025 396
Investment in Plantify [Member]  
Impairment Effects on Earnings Per Share [Line Items]  
Outstanding at December 31, 2024
Additions during the period
Purchase of MitoCareX
Transfers into Level 3 (see Note 10) 782
Changes in fair value (782)
Outstanding at December 31, 2025
Stock Purchase Warrants Liability [Member]  
Impairment Effects on Earnings Per Share [Line Items]  
Outstanding at December 31, 2024
Additions during the period 1,500
Settlements of liabilities (2,769)
Changes in fair value 1,382
Outstanding at December 31, 2025 113
Warrant Lliabilities to Pure Capital [Member]  
Impairment Effects on Earnings Per Share [Line Items]  
Outstanding at December 31, 2024 312
Additions during the period
Settlements of liabilities
Changes in fair value (234)
Outstanding at December 31, 2025 78
Credit Facility [Member]  
Impairment Effects on Earnings Per Share [Line Items]  
Outstanding at December 31, 2024
Additions during the period 1,340
Settlements of liabilities (1,165)
Changes in fair value 62
Outstanding at December 31, 2025 237
Contingent Considerations [Member]  
Impairment Effects on Earnings Per Share [Line Items]  
Outstanding at December 31, 2024
Additions during the period 3,277
Settlements of liabilities
Changes in fair value (1,136)
Outstanding at December 31, 2025 $ 2,141